Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OTIC
5026
CALL
DELISTED
Otonomy, Inc.
OTIC
| $459K | ﹤0.01% |
37,500
-37,500
| -50% | -$546K |
|
|
OTIC
5027
PUT
DELISTED
Otonomy, Inc.
OTIC
| $459K | ﹤0.01% |
+37,500
| New | +$546K |
|
|
WINS
5028
DELISTED
Wins Finance Holdings Inc. Ordinary Shares (Cayman Islands)
WINS
| $458K | ﹤0.01% |
3,159
+1,550
| +96% | +$428K |
|
5029
PUT
Ironwood Pharmaceuticals
IRWD
$614M
| $457K | ﹤0.01% |
+31,999
| New | +$438K |
|
5030
PUT
T. Rowe Price
TROW
$25.6B
| $457K | ﹤0.01% |
6,700
+2,800
| +72% | +$199K |
|
5031
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$84.4M
| $455K | ﹤0.01% |
59
-132
| -69% | -$1.04M |
|
5032
Geospace Technologies
GEOS
$93.1M
| $455K | ﹤0.01% |
28,031
-6,054
| -18% | -$115K |
|
|
INFI
5033
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $455K | ﹤0.01% |
140,737
-72,865
| -34% | -$179K |
|
5034
CALL
Coeur Mining
CDE
$15.9B
| $454K | ﹤0.01% |
56,200
-157,600
| -74% | -$1.5M |
|
5035
CALL
The GEO Group
GEO
$4.1B
| $454K | ﹤0.01% |
14,700
-132,000
| -90% | -$3.79M |
|
5036
PUT
Pitney Bowes
PBI
$2.46B
| $454K | ﹤0.01% |
34,600
+16,400
| +90% | +$232K |
|
5037
Akebia Therapeutics
AKBA
$362M
| $453K | ﹤0.01% |
49,277
+608
| +1% | +$5.93K |
|
|
JONE
5038
DELISTED
Jones Energy, Inc.
JONE
| $453K | ﹤0.01% |
8,877
+6,769
| +321% | +$481K |
|
5039
CALL
ASML
ASML
$634B
| $452K | ﹤0.01% |
3,400
| – | – |
|
5040
Community Trust Bancorp
CTBI
$1.42B
| $452K | ﹤0.01% |
9,883
-2,154
| -18% | -$100K |
|
5041
Cartesian Therapeutics
RNAC
$227M
| $452K | ﹤0.01% |
1,053
+478
| +83% | +$201K |
|
5042
PUT
NCR Voyix
VYX
$1.12B
| $452K | ﹤0.01% |
16,137
+978
| +6% | +$26.8K |
|
|
ZOES
5043
PUT
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $451K | ﹤0.01% |
24,400
+22,300
| +1,062% | +$456K |
|
|
IDTI
5044
PUT
DELISTED
Integrated Device Technology I
IDTI
| $450K | ﹤0.01% |
19,000
-259,800
| -93% | -$6.37M |
|
5045
ProShares Ultra Dow30
DDM
$536M
| $449K | ﹤0.01% |
29,490
-7,200
| -20% | -$107K |
|
5046
PUT
Western Union
WU
$2.4B
| $448K | ﹤0.01% |
22,000
-102,300
| -82% | -$2.09M |
|
5047
Energous
WATT
$77.2M
| $447K | ﹤0.01% |
48
-25
| -34% | -$240K |
|
5048
PUT
Edgewell Personal Care
EPC
$1.26B
| $446K | ﹤0.01% |
6,100
-146,500
| -96% | -$11.2M |
|
5049
iShares MSCI Poland ETF
EPOL
$699M
| $445K | ﹤0.01% |
+20,608
| New | +$427K |
|
|
TPIC
5050
DELISTED
TPI Composites
TPIC
| $444K | ﹤0.01% |
+23,364
| New | +$418K |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.